Immunopathogenesis


Since the onset of the COVID-19 pandemic in the fall of 2019 over 4 million people have been infected and over 280,000 have died (1). Information about the SARS-CoV2 virus is evolving rapidly. At this time there are no interventions proven to be effective for cases infected with SARS-CoV2. Current knowledge about the clinical and laboratory manifestations of COVID-19 infection is reviewed and combined with knowledge about the immunopathogenic mechanisms of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV1) and Middle East Respiratory Syndrome (MERS) to formulate theories and suggest possible therapeutic interventions. SARS-CoV2 immunopathogenic mechanisms vary from immunosuppression that initially enables viral escape to a hyperinflammatory immune response. Ultimately therapeutic intervention will be phase dependent.



 


  • Infection
  • Asymptomatic
  • Symptomatic
  • AIDS/Progression of HIV to AIDS

Related Conference of Immunopathogenesis

June 23-24, 2021

34th World Congress on Vaccines and Immunization

Osaka, Australia
June 24-25, 2021

9th World Summit on immunology & immunotherapy

Prague, Czech Republic
June 29-29, 2021

3rd International Conference on Dermatology and Allergic Diseases

Singapore City, Singapore
July 08-09, 2021

International Online Conference on Immunology

New York, USA
August 27-28, 2021

5th International Conference on Emerging Infectious Diseases

Amsterdam, Netherlands
October 12-13, 2021

International Conference on Vaccine and Vaccine research

Manila, Philippines
October 14-15, 2021

13th Annual Conference on Clinical Immunology

Cape Town, South Africa
October 14-15, 2021

11th International Conference on Bacteriology and Infectious Diseases

Cape Town, South Africa
November 10-11, 2021

International Conference on Immunology Research

New York, USA

Immunopathogenesis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in